New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer patients
A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment. Utilizing lead-212 (212Pb), ...
Apr 16, 2024
0
33
